Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis

The Mayo-2018 smoldering multiple myeloma (SMM) risk score is used routinely in the clinical setting but has only been validated at diagnosis. In SMM patients, the progression risk decreases over time. However, the utility of applying risk stratification models after diagnosis is unknown. We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Visram, Alissa, Rajkumar, S. Vincent, Kapoor, Prashant, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Kourelis, Taxiarchis, Gonsalves, Wilson, Warsame, Rahma, Muchtar, Eli, Leung, Nelson, Baughn, Linda B., Kyle, Robert A., Kumar, Shaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626440/
https://www.ncbi.nlm.nih.gov/pubmed/34836942
http://dx.doi.org/10.1038/s41408-021-00569-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626440/
https://www.ncbi.nlm.nih.gov/pubmed/34836942
http://dx.doi.org/10.1038/s41408-021-00569-2

Ejemplares similares